Loading
A phase 2 trial in pancreatic cancer, run by Barbara Malene Fischer, now recruiting.
BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer is a phase 2, interventional study registered as NCT07629609 by Barbara Malene Fischer, with a registry enrolment figure of 90 participants, started 2024-01-16 and due to reach its primary completion in 2027-01. Interventions recorded: [68Ga]Ga-FAPI-46. Conditions listed: Pancreatic Cancer, Adult; Gastroesophageal Cancer (GC). Primary outcome: Sensitivity of [68Ga]Ga-FAPI-46 Total Body PET/CT. Pancreatic eligibility wording from the registry: "Patients with suspected pancreatic cancer based on morphological findings on standard imaging". Sites: Denmark. No results are recorded here; the registry entry is the source.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.